United Kingdom

People: Stryker Corp (SYK.N)

SYK.N on New York Stock Exchange

9:10pm BST
Change (% chg)

$-4.17 (-1.91%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Scannell, Timothy 

Mr. Timothy J. Scannell is President, Chief Operating Officer of the Company effective August 1, 2018. He began his career with Stryker in 1990 with our Endoscopy division, where he served in various sales and marketing leadership roles. Mr. Scannell progressed to the position of Executive Vice President, overseeing sales, marketing and operations. In 2001, he was appointed Vice President and General Manager of our Biotech division. In 2003, he was named Vice President and General Manager of our Spine division and was later promoted to President of Spine. In 2009, he was appointed to the position of Group President and initially was responsible for the Spine and Endoscopy divisions. Over time, the role expanded to include MedSurg and Neurotechnology, with each of the group’s divisional leaders reporting to him. He serves on the Board of Directors for Insulet Corporation, whose OmniPod®Insulin Management System helps to improve the lives of people with diabetes.

Basic Compensation

Total Annual Compensation, USD 691,250
Restricted Stock Award, USD 3,380,330
Long-Term Incentive Plans, USD --
All Other, USD 2,560,600
Fiscal Year Total, USD 6,632,180

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 85,000 8,021,450.00
Name Fiscal Year Total

Kevin Lobo


Timothy Scannell


Glenn Boehnlein


Viju Menon


M. Kathryn Fink


Bijoy Sagar

As Of  31 Dec 2018